A Built-In Pain-Suppression System
The nervous system has an in-built mechanism by which one painful or strongly stimulating input can inhibit the perception of pain elsewhere in the body — originally described in animal studies as diffuse noxious inhibitory control (DNIC), and now more commonly studied in humans under the term conditioned pain modulation, or CPM (Le Bars et al., 1979; Yarnitsky, 2010).
How It Is Thought to Work
A sufficiently strong sensory or nociceptive input engages descending pathways originating in the brainstem that suppress incoming pain signals at the level of the spinal cord, broadly — not just at the specific segment being stimulated. This is one plausible explanation for why treating a tight, restricted area in one part of the body can be followed by a reduction in symptoms somewhere else entirely, even where the two areas share no direct anatomical or neurological pathway.
Why This Matters Clinically
An efficiently functioning CPM response is generally considered a marker of a healthy, well-regulated pain system, while a blunted or absent CPM response has been associated with several chronic pain conditions. This gives clinicians a physiologically grounded reason to treat broadly and systemically rather than assuming benefit can only come from working directly on the specific painful structure.
References & Further Reading
- Le Bars D, Dickenson AH, Besson JM. Diffuse noxious inhibitory controls (DNIC). I. Effects on dorsal horn convergent neurones in the rat. Pain. 1979;6(3):283-304.
- Yarnitsky D. Conditioned pain modulation (the diffuse noxious inhibitory control-like effect): its relevance for acute and chronic pain states. Curr Opin Anaesthesiol. 2010;23(5):611-615.